STIM stock forecast
Our latest prediction for Neuronetics, Inc.'s stock price was made on the March 10, 2020 when the stock price was at 2.05$.
In the short term (2weeks), STIM's stock price should outperform the market by 5.67%. During that period the price should oscillate between -11.78% and +27.44%.
In the medium term (3months), STIM's stock price should outperform the market by 5.95%. During that period the price should oscillate between -34.72% and +70.58%.Get email alerts
Create a solid portfolio with STIM
About Neuronetics, Inc.
Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.
At the moment the company generates 63M USD in revenues.
On its last earning announcement, the company reported a loss of -1.58$ per share.
The book value per share is 3.57$
Three months stock forecastMarch 10, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|